Brought to you by:
Advances in endovascular therapy help drive innovative CPVI training course
The SVS Complex Peripheral Vascular Interventions (CPVI) Skills Course has become a fixture on the vascular surgery calendar over the past couple of years. Here, course director Vipul Khetarpaul, MD, gives Marlén Gomez the rundown on how the evolution of…
SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials. In addition, higher five-year mortality with drug-coated devices in patients with intermittent…
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year period
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic limb threatening ischemia (CLTI) patients over the past two decades found that they had “significantly improved”…
First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI
AngioDynamics today announced enrollment of the first patient in AMBITION BTK, a randomized study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischemia (CLTI). A press release details that AMBITION BTK is a prospective, multicenter, randomized controlled…
Complex PAD skills course registration is open
Registration is now open for the Society for Vascular Surgery (SVS) Complex Peripheral Vascular Interventions (CPVI) Skills Course, taking place from Sept. 20–21 in Rosemont, Illinois. The two-day course will provide participants with hands-on training in the latest techniques and…
Novel MRI technique for CLTI poised to address ‘medieval problem in modern medicine’
“We want to change global standards. What we’re doing isn’t working. Patients are getting hurt and devices are failing—we want to be able to make sure devices we’re using today are safe, so that we can build new devices that…
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in South Asia, attendees of the International Chapter Education Session at VAM 2025 heard yesterday morning. That…
Transcatheter arterialization of the deep veins: Comparative analysis probes whether emerging modality is worth pursuing
“We’re living in a new world order” when it comes to “no-option” chronic limb-threatening ischemia (CLTI) patients, says Anahita Dua, MD. In recent years, into this arena has stepped transcatheter arterialization of the deep veins (TADV), raising hopes of reducing…
What the cost of cancer care teaches vascular specialists
How does the cost of treating critical limb-threatening ischemia (CLTI) in the U.S. stack up to cancer care? That was the question at the heart of research conducted by Richard W. Walsh, MD, and colleagues at the University of Texas…
Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
The open surgical approach will prove to be “slightly superior” to endovascular intervention in terms of cost per life year gained, while the latter will be slightly superior to open surgery with regard to cost per quality-adjusted life year gained,…